top of page
Our Founders
Our Founders
Our Founders
Home
Leadership
News
Investors
Contact
MORE
Use tab to navigate through the menu items.
Focused on Cancer
with an Eye
Toward the Future
Recent News
April 29, 2024:
Mosaic ImmunoEngineering Agrees to Acquire Clinical Necroptosis Cancer Therapy Assets from Oncotelic Therapeutics, Inc.
bottom of page
